Literature DB >> 12075496

[Current epidemiology of carcinoma of the esophagus and cardia in Germany].

D Bareiss1, R Stabenow, R Müller, B Eisinger, C Stegmaier, P Däubler, M Zeitz, H Scherübl.   

Abstract

BACKGROUND AND
OBJECTIVE: In the past 20-30 years the incidence of adenocarcinoma (AC) of the esophagus and the cardia has risen in western countries, while that of squamous cell carcinoma (SC) of the esophagus has largely stayed constant. Current data in the epidemiology of these cancers in Germany were analysed. METHODS AND MATERIAL: The data of the epidemiological cancer register of the Saarland (Old State of former West Germany) and the combined registers of the New States of Germany (former East Germany) and Berlin were collected. Because of the excellent registration procedures, data from the Saarland and the New States, Mecklenburg-Pommern, Brandenburg and Saxony were selected for this study. The incidence was calculated and corrected for age in relation to the world population.
RESULTS: The incidence of esophageal AC among males in the Saarland rose from 0.22 per 100 000 population to 1.17 between 1986 to 1997, an increase of 432%, while in Brandenburg, Mecklenburg-Vorpommern and Saxomy it rose, between 1977 and 1998, from 0.23 to 0.8 i.e. by 248%. Esophageal SC incidence remained largely constant in both cancer registers since 1986. In 1998 it was 3.31 in the three New States of Germany and 5.05 in the Saarland. In females the incidence was markedly lower. In 1996-1998 fewer than 10% of cases of esophageal cancer were in UICC stage 1 (T 1 N 0 M 0, early carcinoma). Correspondingly the 5-year survival of all patients with esophageal carcinoma in the Saarland was less than 10% in 1971-1995. AC of the cardia also increased. In the three New States of Germany the incidence among males rose from 1.27 in 1977 to 2.18 in 1998, in females from 0.4 to 0.58. During the same period malignant tumors of the entire stomach, including the cardia, decreased in males from 29.5 to 17.1, in females from 14.3 to 9.2.
CONCLUSION: In Germany, during the past 15-20 years, the incidence of esophageal AC and presumably also of AC of the cardia has increased. But the incidence of squamous cell carcinoma of the esophagus has remained largely constant. The proportion of early carcinoma and the 5-year survival with esophageal carcinoma remains under 10%.

Entities:  

Mesh:

Year:  2002        PMID: 12075496     DOI: 10.1055/s-2002-32375

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  9 in total

1.  [Barrett esophagus: epidemiology, incidence of carcinoma, need for screening].

Authors:  R Arnold; M Wied
Journal:  Internist (Berl)       Date:  2003-01       Impact factor: 0.743

Review 2.  [MSCT for staging and response evaluation of esophageal cancer].

Authors:  K Holzapfel; E J Rummeny; C Hannig; A J Beer
Journal:  Radiologe       Date:  2007-02       Impact factor: 0.635

3.  Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer.

Authors:  Lin Cai; Zong-Li Zheng; Zuo-Feng Zhang
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

Review 4.  Barrett's esophagus and Barrett's carcinoma.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Jörg R Siewert
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

5.  A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism.

Authors:  Zhen Cai; Jiang-Sha Zhao; Jing-Jing Li; Dan-Ni Peng; Xiao-Yan Wang; Tian-Lu Chen; Yun-Ping Qiu; Ping-Ping Chen; Wen-Jie Li; Li-Yan Xu; En-Ming Li; Jason P M Tam; Robert Z Qi; Wei Jia; Dong Xie
Journal:  Mol Cell Proteomics       Date:  2010-08-10       Impact factor: 5.911

6.  [Mucosectomy as sufficient therapy for early squamous cell].

Authors:  M Jung
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

7.  A pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma.

Authors:  F Mühr-Wilkenshoff; W Hinkelbein; I Ohnesorge; K J Wolf; E-O Riecken; M Zeitz; H Scherübl
Journal:  Int J Colorectal Dis       Date:  2003-02-01       Impact factor: 2.571

Review 8.  [Coincidental squamous cell cancers of the esophagus, head, and neck: risk and screening].

Authors:  H Scherübl; J Steinberg; C Schwertner; P Mir-Salim; U Stölzel; E-M de Villiers
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

9.  [Prevention of gastrointestinal malignancies].

Authors:  A Hoffmeister; I Schiefke; N Teich; J Mössner; K Schoppmeyer
Journal:  Internist (Berl)       Date:  2008-02       Impact factor: 0.743

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.